NEW VITAMIN D DERIVATIVES WITH CYCLIC SUBSTRUCTURES IN THE SIDE CHAINS, METHOD AND INTERMEDIATES FOR THEIR PRODUCTION AND THEIR USE IN THE PREPARATION OF MEDICAMENTS

摘要

Vitamin D derivatives (I), having a cyclic substituent in the side-chain, are new. Also new are perhydroindane derivative intermediates (A) ands (B). Vitamin D derivatives of formula (I), including all possible epimers, diastereomers and their mixtures, are new. Y1, Y2 = H or -C(O)R5; Y3 (in alpha- or beta-configuration) = H, OH, halo, OC(O)R5 or OR5; R5 = 5-12C aromatic residue; or 1-12C optionally unsaturated alkyl (optionally interrupted by 1 or 2 O, 1 or 2 S and/or 1 or 2 NH; and optionally substituted by 1 or 2 OH, 1 or 2 NH2, 1 or 2 SH, 1 or 2 COOH and/or 1 or 2 COOH); R1, R2 = H or together form exocyclic =CH2; R3, R4 = H, F, Cl, Br or 1-4C alkyl; or CR3R4 = -C(=CH2)- or a 3-7 membered saturated or unsaturated carbocyclic ring; Q = 1-5C n-alkylene; X1, X2 = H, OH, OC(O)R5, F, Cl or Br (but not both OH or both -OC(O)R5); or CX1X2 = C=O; Z' = carbocyclic or heterocyclic (including aromatic or heteroaromatic) ring system comprising a 5- or 6-membered ring optionally fused with a 6-membered ring (optionally substituted by one or more of each of halo, OH, COOR6 or 1-5C alkyl (itself optionally substituted by one or more of halo, 1-6C alkoxy and/or COOR6)); R6 = 1-6C alkyl, benzyl or phenyl. Independent claims are included for: (1) new perhydroindane derivative intermediates of formulae (A) and (B); (2) preparation of perhydroindane derivative intermediates of formula (XIIIa) by: (a) reacting a perhydroindane derivative of formula (A; T replaced by L) with protected, deprotonated propargyl alcohol to give (A; T = -CC-CH2OY5), (b) hydrogenating and deprotecting to give (A; T = -(CH2)3OH), (c) oxidizing to give (A; T = -CH2CH2CHO) and (d) reacting with a nucleophile Nu, cleaving Y4 and oxidizing the free OH group; and (3) preparation of vitamin D compounds of formula (IIa) by: (a) reacting a ketone of formula (XIIIb) with a trimethylsilyl acetoacetate ester in presence of a base or with a Wittig reagent in an aprotic solvent to give (B; U = COOR6), (b) reducing to give (B; U = CH2OH), (c) converting into (B; U replaced by L), (d) converting into the Wittig reagent (B; U = CH2P(O)(G)2) and (e) reacting with a ketone of formula (XXXIII) and optionally deprotecting the product. T = -CC-CH2OY5, -(CH2)3OH or -CH2CH2CHO; Y4 = trialkylsilyl, mixed aryl-alkyl substituted silyl, tetrahydropyranyl or tetrahydrofuranyl protective group; Y5 = tetrahydropyranyl or benzyl; E = side-chain, in which any keto and/or hydroxy groups are protected; U = COOR6, CH2OH or CH2P(O)(G)2; Y6 = 1-6C alkyl, benzyl or phenyl; G = 1-10C alkyl, 1-10C alkoxy, Ph or OPh; L = leaving group; Nu = nucleophile; R7, R8 = H or Me; or together form exocyclic =CH2 or a cyclopropane ring; Y6 = F, (CH2)nOH or (CH2)nOCOR5; n = 0-4; Y'1 = hydroxy-protecting group; Y'3 = H, halo or as Y'1.